Clinical Trials
37 trialsNCT06048094 2026-05-20
FACILITATE
Baptist Health South Florida
Phase 1 Recruiting
NCT05053152 2026-05-04
Testing the Addition of the Drug Relugolix to the Usual Radiation Therapy for Advanced-Stage Prostate Cancer, The NRG Promethean Study
NRG Oncology
Phase 2 Active not recruiting
NCT05555550 2026-04-29
Evaluation of 18F-Fluciclovine Positron Emission Tomography - Magnetic Resonance Imaging (PET-MRI) in LGG
Children's Hospital of Philadelphia
Phase EARLY_PHASE1 Recruiting
NCT04689048 2026-04-22
Assess Use of 18F-Fluciclovine for Patients With Large Brain Metastases Treated With Staged Stereotactic Radiosurgery
Baptist Health South Florida
Phase 1 Recruiting
NCT04018053 2026-01-27
18Fluorine-Fluciclovine PET/CT for Staging Muscle Invasive Bladder Cancer Preceding Radical Cystectomy
Brigham and Women's Hospital
Phase EARLY_PHASE1 Active not recruiting
NCT05553041 2025-12-04
18F-Fluciclovine PET-MRI in High-grade Glioma
Children's Hospital of Philadelphia
Phase EARLY_PHASE1 Recruiting
NCT05554302 2025-12-01
CONCORDANT
Baptist Health South Florida
Phase 2 Recruiting
NCT06613841 2025-11-28
GBM
Abramson Cancer Center at Penn Medicine
Phase EARLY_PHASE1 Recruiting
NCT05722925 2025-11-14
Evaluating Fluciclovine PET in Patients With Biochemical Recurrence of Prostate Cancer and a Negative PSMA PET
OHSU Knight Cancer Institute
Phase 4 Active not recruiting
NCT06062745 2025-11-05
Pilot Study for Detection of PSMA-Low CRPC-NE Tumors With Fluciclovine PET/CT
Brigham and Women's Hospital
Phase 1 Recruiting
NCT04158245 2025-09-22
18F-fluciclovine PET in Metastatic Castration Resistant Prostate Cancer Treated With Life Prolonging Therapies
Tulane University
Phase 2 Completed
NCT04750473 2025-01-17
Fluciclovine and PSMA PET/CT for the Classification and Improved Staging of Invasive Lobular Breast Cancer
Emory University
Phase 1 Completed
NCT04134208 2025-01-16
An Investigational Scan (18F-Fluciclovine PET-CT) for the Measurement of Therapeutic Response in Patients With Metastatic Prostate Cancer
M.D. Anderson Cancer Center
Phase 4 Terminated
NCT03276676 2024-12-27
[18F]Fluciclovine and [18F]FLT PET/CT Assessment of Primary High-Grade Brain Tumors
University of Utah
Phase 1/2 Terminated
NCT03707184 2024-11-29
Fluciclovine F18 PET/CT Imaging in Assessing Hormone-Naive Men With Prostate Cancer That Has Spread to the Bone
University of Utah
Phase 2 Completed
NCT03926507 2024-10-09
F18 Fluciclovine PET/CT in Assessing Tumor Volume and Radiation Therapy Response in Patients With Glioblastoma Undergoing Surgery
M.D. Anderson Cancer Center
Phase NA Completed
NCT03925675 2024-09-03
18F-Fluciclovine PET and Multiparametric MR Imaging
Loma Linda University
Phase 2 Withdrawn
NCT03762759 2024-05-17
Fluciclovine F18 or Ga68-PSMA PET/CT to Enhance Prostate Cancer Outcomes
Emory University
Phase 2 Unknown
NCT03868020 2024-03-28
Fluciclovine F18 PET/CT in Identifying the Origin of Head and Neck Squamous Cell Carcinoma in Patients With Metastatic Cervical Nodal Disease
M.D. Anderson Cancer Center
Phase EARLY_PHASE1 Completed
NCT05035732 2024-01-18
A Prospective Pilot Study for the Evaluation of 18F- Fluciclovine PET/MRI in Radio-recurrent Prostate Cancer (RRPC-PET/MRI Study)
M.D. Anderson Cancer Center
Phase NA Withdrawn
NCT05054400 2023-09-01
Study of Laser Interstitial Thermal Therapy (LITT) Treatment Response Assessment With Fluciclovine PET MR
M.D. Anderson Cancer Center
Phase EARLY_PHASE1 Withdrawn
NCT01666808 2023-08-02
FACBC Outcomes for Post Prostatectomy
Emory University
Phase 2/3 Completed
NCT04114370 2022-12-06
FACBC
University of Pittsburgh
Phase EARLY_PHASE1 Completed
NCT05479136 2022-10-27
DRARCH
St. Joseph's Hospital and Medical Center, Phoenix
Phase 3 Unknown
NCT03990285 2021-12-22
Axumin
Abramson Cancer Center at Penn Medicine
Phase 1 Completed
NCT03930173 2021-05-05
18F-Fluciclovine PET to Distinguish Tumor Progression From Radiation Necrosis
Case Comprehensive Cancer Center
Phase EARLY_PHASE1 Completed
NCT03263780 2021-02-21
High Resolution PET-MRI Before Prostate Cancer HIFU
Cedars-Sinai Medical Center
Phase 2 Completed
NCT03081884 2021-01-25
EDRN-FACBC
Emory University
Phase 2 Completed
NCT03423082 2020-10-28
Pilot Study to Assess the Potential Clinical Utility of 18F Fluciclovine PET for Cervical and Endometrial Cancer.
University of Pittsburgh
Phase 4 Terminated
NCT03515577 2020-10-14
PSMA vs AXUMIN
Jonsson Comprehensive Cancer Center
Phase 2 Completed
NCT03264456 2020-03-09
Pretreatment Staging of High-Risk Prostate Cancer With 18F-Fluciclovine PET/MRI
University of Alabama at Birmingham
Phase 1/2 Completed
NCT03349463 2020-02-28
Evaluation of Fluciclovine Uptake in Patients With Cervical, Ovarian Epithelial or Endometrial Cancers.
Loyola University
Phase 4 Unknown
NCT02830880 2020-01-07
FACBC Prostate Therapy Response
Emory University
Phase 2 Completed
NCT01808222 2019-01-07
FACBC for Recurrent Prostate Cancer
Emory University
Phase 2 Completed
NCT03036943 2018-12-19
FRONTIER
University of Oxford
Phase NA Completed
NCT00562315 2016-06-21
FACBC PET/CT for Recurrent Prostate Cancer
Emory University
Phase 2 Completed
NCT00917865 2014-01-07
FACBC Positron Emission Tomography/Computed Tomography(PET/CT) Used in the Diagnosis of Primary Prostate Cancer
Emory University
Phase 2 Terminated